Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
about
Interactome mapping suggests new mechanistic details underlying Alzheimer's diseaseMitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based TherapiesProteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's DiseaseA review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditionsMitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular DysfunctionCalcium channel blockers and Alzheimer's diseaseBcl-x(L) blocks a mitochondrial inner membrane channel and prevents Ca2+ overload-mediated cell deathThe Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's DiseasePantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted stateAmyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive declineEpigenetic signature and enhancer activity of the human APOE gene.A review of β-amyloid neuroimaging in Alzheimer's disease.AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and NeuronsMitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease.Nicotinamide Reduces Amyloid Precursor Protein and Presenilin 1 in Brain Tissues of Amyloid Beta-Tail Vein Injected MiceUnlocking the Door to Neuronal Woes in Alzheimer's Disease: Aβ and Mitochondrial Permeability Transition PoreXanthoceraside ameliorates mitochondrial dysfunction contributing to the improvement of learning and memory impairment in mice with intracerebroventricular injection of aβ1-42.Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synucleinBetanodavirus B2 causes ATP depletion-induced cell death via mitochondrial targeting and complex II inhibition in vitro and in vivo.Upregulation of human PINK1 gene expression by NFκB signallingMicroglial P2X₇ receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease.Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's diseaseMitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.Three-dimensional analysis of abnormal ultrastructural alteration in mitochondria of hippocampus of APP/PSEN1 transgenic mouse.Metabotyping of docosahexaenoic acid - treated Alzheimer's disease cell modelThe role of mitochondrial DNA mutation on neurodegenerative diseases.Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's diseaseHow the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenarioMitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic miceMitochondria as a therapeutic target for aging and neurodegenerative diseases.Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation.High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity
P2860
Q24317038-7F88DDC4-DC5D-4F0B-A6E2-56F1867A5020Q26750081-E536DF73-E5A5-4FC5-A2AC-46B7E0447BBBQ26777933-5A2E948A-B3A8-4D16-AB77-553DD9DC674FQ26781560-6FF699CE-A220-43DB-8B68-9C4EF1624A77Q26799985-234CD30C-4ACD-4067-891A-3C3B9A3F2D9CQ26866552-F8480399-37C3-4DB3-8DAE-C620C638FCC3Q27338716-3A5BCA09-633B-48B1-8784-A3061C40F9BCQ28254943-03BFCA76-17CD-4B88-8A2E-473DA4556B99Q28474360-9A8348CC-12FD-4907-9C9D-82BB69997A9BQ30476347-A5E8047E-5DAD-493C-88AE-DADC224F88CFQ30557542-DF7CC9A6-7733-4F0A-8DB8-384CEF86BA1CQ30870063-3C05CE5D-5FD5-48AE-AE37-8153C8FC6CF9Q31071777-E7BCBFC2-5445-4B3D-BB40-A21C32CB7BD7Q33519068-C33A8AB9-A207-4FEC-9536-D0DDAC6DDB0BQ33661240-97DB145D-90CA-4B3F-BF78-A8316B355AE0Q33664175-F9D5FA77-9749-4D69-9A77-33413D4684BFQ33757597-F7414E6A-4FBF-464F-B453-676E970FEECAQ33915362-5C131364-2EAF-47A9-A434-746EE384C612Q34028039-D8CC4BF6-1D1F-4ACF-808A-8BD8B494834CQ34054660-5D08EEC2-0082-4239-8AED-12E5BA027425Q34127614-D6274476-F6B9-4B30-8F3B-C520C1F4CAFEQ34193337-B04CA9D0-7B31-4A8F-BD69-3F7FD2266223Q34207247-87048A0F-81EA-441D-B892-4FC6F2C4A7EDQ34400867-55298EB4-9B2F-4C79-90C5-2DEE2A924182Q34545300-0EB8F414-1378-43FC-8BB6-B2791AB3D458Q34587134-14E07401-7969-4C3B-9D5B-25AA093C5596Q34590202-310C78F8-87ED-4C88-9885-E679244F71F9Q34627072-A52ECAC1-9604-450B-8ABB-8CA54A06B7B8Q34667337-6197F910-055E-448E-BFA0-250177B333FEQ34772619-E5C5D243-563B-41D1-9933-849FE70FEB54Q35086993-2CDBCEF1-43C6-4066-A711-5BDD4938F077Q35108713-843C7A1D-AAB8-4F74-8724-BFB2ED7D328EQ35152954-BC87A582-0A02-4313-AC48-AB7D1398E345Q35532902-B0152E57-D7BF-417D-8926-16FC16B12619Q35569964-2934977E-2508-4250-8A14-A73A97AB5339Q35577446-1B5449DA-12A0-4295-869D-FC646BDD5885Q35807409-47ED63C4-B0A9-4DAB-BEE2-0FBC987A140EQ35895780-38071BB5-D1E0-441C-BD55-5031A515A4AEQ35898639-16C31DE9-2DAF-45E2-8703-E8265735FDA6Q36042018-1EEB3573-9AED-4852-A5D5-771ECEDB5899
P2860
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
@en
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
@nl
type
label
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
@en
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
@nl
prefLabel
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
@en
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
@nl
P2860
P1476
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
@en
P2093
P Hemachandra Reddy
P2860
P304
P356
10.1016/J.EXPNEUROL.2009.03.042
P407
P577
2009-04-07T00:00:00Z